James Wassil
Chief Operating Officer chez VAXCYTE, INC.
Fortune : 15 M $ au 31/03/2024
Profil
James Wassil is currently the Chief Operating Officer & Executive Vice President at Vaxcyte, Inc. He previously worked as the Vice President-Global Health & Value Business at Pfizer Inc. and as the Head-Global Product Development at Novartis AG.
He also served as the Senior Director-International Marketing at Merck & Co., Inc. and as an Independent Director at Icosavax, Inc. Additionally, he is a member of the Infectious Diseases Society of America.
Wassil received his undergraduate degree from the University of Notre Dame and his graduate and MBA degrees from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXCYTE, INC.
0,20% | 17/04/2024 | 221 840 ( 0,20% ) | 15 M $ | 31/03/2024 |
Postes actifs de James Wassil
| Sociétés | Poste | Début |
|---|---|---|
| VAXCYTE, INC. | Chief Operating Officer | 01/12/2019 |
Anciens postes connus de James Wassil
| Sociétés | Poste | Fin |
|---|---|---|
| ICOSAVAX, INC. | Director/Board Member | 19/02/2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01/12/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/05/2015 |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Sales & Marketing | - |
Formation de James Wassil
| University of Notre Dame | Undergraduate Degree |
| Lehigh University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
